Matthew Falagas
Matthew Falagas
European University Cyprus, Nicosia / AIBS & Hygeia Hospital, Athens / Tufts University, Boston
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
AP Magiorakos, A Srinivasan, RB Carey, Y Carmeli, ME Falagas, ...
Clinical microbiology and infection 18 (3), 268-281, 2012
Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses
ME Falagas, EI Pitsouni, GA Malietzis, G Pappas
The FASEB journal 22 (2), 338-342, 2008
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas, SK Kasiakou, LD Saravolatz
Clinical infectious diseases 40 (9), 1333-1341, 2005
Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
G Pappas, N Roussos, ME Falagas
International journal for parasitology 39 (12), 1385-1394, 2009
Obesity and infection
ME Falagas, M Kompoti
The Lancet infectious diseases 6 (7), 438-446, 2006
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
ME Falagas, SK Kasiakou
Critical care 10, 1-13, 2006
Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review
PI Rafailidis, EG Mourtzoukou, IC Varbobitis, ME Falagas
Virology journal 5, 1-7, 2008
Comparison of SCImago journal rank indicator with journal impact factor
ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos
The FASEB journal 22 (8), 2623-2628, 2008
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
DE Karageorgopoulos, ME Falagas
The Lancet infectious diseases 8 (12), 751-762, 2008
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa
ME Falagas, PK Koletsi, IA Bliziotis
Journal of medical microbiology 55 (12), 1619-1629, 2006
Extended-spectrum β-lactamase-producing organisms
ME Falagas, DE Karageorgopoulos
Journal of Hospital infection 73 (4), 345-354, 2009
ME Falagas, EK Vouloumanou, G Samonis, KZ Vardakas
Clinical microbiology reviews 29 (2), 321-347, 2016
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos
The Lancet infectious diseases 10 (1), 43-50, 2010
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis
DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ...
Clinical Infectious Diseases 52 (6), 750-770, 2011
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections
ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas
Emerging infectious diseases 20 (7), 1170, 2014
Epidemiology of constipation in Europe and Oceania: a systematic review
G Peppas, VG Alexiou, E Mourtzoukou, ME Falagas
BMC gastroenterology 8, 1-7, 2008
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
ME Falagas, IA Bliziotis
International journal of antimicrobial agents 29 (6), 630-636, 2007
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations
J Ariza, M Bosilkovski, A Cascio, JD Colmenero, MJ Corbel, ME Falagas, ...
PLOS medicine 4 (12), e317, 2007
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis
KA Polyzos, AA Konstantelias, ME Falagas
Ep Europace 17 (5), 767-777, 2015
Sex differences in the incidence and severity of respiratory tract infections
ME Falagas, EG Mourtzoukou, KZ Vardakas
Respiratory medicine 101 (9), 1845-1863, 2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20